Murine models of chronic Pseudomonas aeruginosa lung infection
- PMID: 12144741
- DOI: 10.1258/002367702320162405
Murine models of chronic Pseudomonas aeruginosa lung infection
Abstract
The animal model of chronic bronchopulmonary infection using agarose beads laden with Pseudomonas aeruginosa is frequently utilized in cystic fibrosis research, though it is challenging to perform it in mice. This paper reports the most successful methods for the creation of this model. Transtracheal insertion of a 22 G 1" over-the-needle intravenous catheter to preferentially inoculate the right mainstem bronchus using tribromoethanol anaesthesia administered i.p. was better for a successful surgical outcome compared, respectively, to the use of a 27 G (1/2)" needle, bilateral inoculation or an anaesthetic cocktail of xylazine, acepromazine and ketamine administered i.p. Bilateral infection was associated with higher mortality, greater weight loss and higher levels of bronchoalveolar cytokine concentration, compared to mice infected primarily in the right lung. Mucoid clinical strain PA M57-15 was preferred since mucoid clinical strain PA 2192 led to comparatively more severe lesions and higher mortality. Using the same operator for a given task reduced the variability inherent in this model, illustrated using outcome measures such as gross lung pathology. The response of mice inoculated with P. aeruginosa-laden agarose beads was characterized by bronchopulmonary inflammation, high production of cytokines, and significant weight loss; whereas the response to infection with free-living bacteria was characterized by pneumonia, lower production of cytokines and weight loss. The use of free P. aeruginosa pre-mixed with sterile agarose beads may be considered as an alternative to the use of P. aeruginosa-laden agarose beads, since the histopathological features were similar, though further characterization is needed to evaluate its utility as an adequate model of cystic fibrosis.
Similar articles
-
Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.Am J Respir Crit Care Med. 2006 Feb 1;173(3):288-96. doi: 10.1164/rccm.200506-917OC. Epub 2005 Nov 4. Am J Respir Crit Care Med. 2006. PMID: 16272448 Free PMC article.
-
Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice.Am J Respir Crit Care Med. 2000 Jan;161(1):271-9. doi: 10.1164/ajrccm.161.1.9903019. Am J Respir Crit Care Med. 2000. PMID: 10619831
-
Effects of bronchopulmonary inflammation induced by pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice.Gene Ther. 1998 Mar;5(3):345-51. doi: 10.1038/sj.gt.3300593. Gene Ther. 1998. PMID: 9614554
-
Novel understandings of host cell mechanisms involved in chronic lung infection: Pseudomonas aeruginosa in the cystic fibrotic lung.J Infect Public Health. 2019 Mar-Apr;12(2):242-246. doi: 10.1016/j.jiph.2018.10.014. Epub 2018 Nov 17. J Infect Public Health. 2019. PMID: 30459101 Review.
-
Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.Behring Inst Mitt. 1997 Feb;(98):269-73. Behring Inst Mitt. 1997. PMID: 9382750 Review.
Cited by
-
Dietary n-3 fatty acids have suppressive effects on mucin upregulation in mice infected with Pseudomonas aeruginosa.Respir Res. 2007 Jun 5;8(1):39. doi: 10.1186/1465-9921-8-39. Respir Res. 2007. PMID: 17550583 Free PMC article.
-
Mice with lung airway ciliopathy develop persistent Mycobacterium abscessus lung infection and have a proinflammatory lung phenotype associated with decreased T regulatory cells.Front Immunol. 2022 Nov 25;13:1017540. doi: 10.3389/fimmu.2022.1017540. eCollection 2022. Front Immunol. 2022. PMID: 36505420 Free PMC article.
-
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics.Cells. 2023 Jan 3;12(1):199. doi: 10.3390/cells12010199. Cells. 2023. PMID: 36611992 Free PMC article. Review.
-
Probability of Target Attainment of Tobramycin Treatment in Acute and Chronic Pseudomonas aeruginosa Lung Infection Based on Preclinical Population Pharmacokinetic Modeling.Pharmaceutics. 2022 Jun 11;14(6):1237. doi: 10.3390/pharmaceutics14061237. Pharmaceutics. 2022. PMID: 35745809 Free PMC article.
-
PvdQ Quorum Quenching Acylase Attenuates Pseudomonas aeruginosa Virulence in a Mouse Model of Pulmonary Infection.Front Cell Infect Microbiol. 2018 Apr 26;8:119. doi: 10.3389/fcimb.2018.00119. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 29755959 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources